FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606719182> ?p ?o ?g. }

• W2606719182 endingPage "e62" @default.
• W2606719182 startingPage "e62" @default.
• W2606719182 abstract "Oral chemotherapy is increasingly used in place of traditional intravenous chemotherapy to treat patients with cancer. While oral chemotherapy includes benefits such as ease of administration, convenience, and minimization of invasive infusions, patients receive less oversight, support, and symptom monitoring from clinicians. Additionally, adherence is a well-documented challenge for patients with cancer prescribed oral chemotherapy regimens. With the ever-growing presence of smartphones and potential for efficacious behavioral intervention technology, we created a mobile health intervention for medication and symptom management.The objective of this study was to develop and evaluate the usability and acceptability of a smartphone app to support adherence to oral chemotherapy and symptom management in patients with cancer.We used a 5-step development model to create a comprehensive mobile app with theoretically informed content. The research and technical development team worked together to develop and iteratively test the app. In addition to the research team, key stakeholders including patients and family members, oncology clinicians, health care representatives, and practice administrators contributed to the content refinement of the intervention. Patient and family members also participated in alpha and beta testing of the final prototype to assess usability and acceptability before we began the randomized controlled trial.We incorporated app components based on the stakeholder feedback we received in focus groups and alpha and beta testing. App components included medication reminders, self-reporting of medication adherence and symptoms, an education library including nutritional information, Fitbit integration, social networking resources, and individually tailored symptom management feedback. We are conducting a randomized controlled trial to determine the effectiveness of the app in improving adherence to oral chemotherapy, quality of life, and burden of symptoms and side effects. At every stage in this trial, we are engaging stakeholders to solicit feedback on our progress and next steps.To our knowledge, we are the first to describe the development of an app designed for people taking oral chemotherapy. The app addresses many concerns with oral chemotherapy, such as medication adherence and symptom management. Soliciting feedback from stakeholders with broad perspectives and expertise ensured that the app was acceptable and potentially beneficial for patients, caregivers, and clinicians. In our development process, we instantiated 7 of the 8 best practices proposed in a recent review of mobile health app development. Our process demonstrated the importance of effective communication between research groups and technical teams, as well as meticulous planning of technical specifications before development begins. Future efforts should consider incorporating other proven strategies in software, such as gamification, to bolster the impact of mobile health apps. Forthcoming results from our randomized controlled trial will provide key data on the effectiveness of this app in improving medication adherence and symptom management.ClinicalTrials.gov NCT02157519; https://clinicaltrials.gov/ct2/show/NCT02157519 (Archived by WebCite at http://www.webcitation.org/6prj3xfKA)." @default.
• W2606719182 created "2017-04-28" @default.
• W2606719182 creator A5017597094 @default.
• W2606719182 creator A5022102010 @default.
• W2606719182 creator A5030548583 @default.
• W2606719182 creator A5049930331 @default.
• W2606719182 creator A5055898059 @default.
• W2606719182 creator A5066004376 @default.
• W2606719182 creator A5085558902 @default.
• W2606719182 creator A5091913728 @default.
• W2606719182 date "2017-04-20" @default.
• W2606719182 modified "2023-10-01" @default.
• W2606719182 title "Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and Development" @default.
• W2606719182 cites W121414984 @default.
• W2606719182 cites W1532052933 @default.
• W2606719182 cites W1905936368 @default.
• W2606719182 cites W1985265935 @default.
• W2606719182 cites W1991660416 @default.
• W2606719182 cites W1995705474 @default.
• W2606719182 cites W1999948915 @default.
• W2606719182 cites W2013528620 @default.
• W2606719182 cites W2021825713 @default.
• W2606719182 cites W2023718959 @default.
• W2606719182 cites W2034606703 @default.
• W2606719182 cites W2039609860 @default.
• W2606719182 cites W2042370231 @default.
• W2606719182 cites W2045026063 @default.
• W2606719182 cites W2048799165 @default.
• W2606719182 cites W2050881365 @default.
• W2606719182 cites W2056183152 @default.
• W2606719182 cites W2065765677 @default.
• W2606719182 cites W2072181779 @default.
• W2606719182 cites W2077637101 @default.
• W2606719182 cites W2083580282 @default.
• W2606719182 cites W2095700614 @default.
• W2606719182 cites W2101771403 @default.
• W2606719182 cites W2104743809 @default.
• W2606719182 cites W2111675414 @default.
• W2606719182 cites W2114574065 @default.
• W2606719182 cites W2122987399 @default.
• W2606719182 cites W2123284020 @default.
• W2606719182 cites W2123311002 @default.
• W2606719182 cites W2140737508 @default.
• W2606719182 cites W2148566563 @default.
• W2606719182 cites W2155002669 @default.
• W2606719182 cites W2157753937 @default.
• W2606719182 cites W2158794403 @default.
• W2606719182 cites W2182819963 @default.
• W2606719182 cites W2284819073 @default.
• W2606719182 cites W2325182804 @default.
• W2606719182 cites W2490180822 @default.
• W2606719182 cites W2508495213 @default.
• W2606719182 cites W2537721985 @default.
• W2606719182 cites W2590511099 @default.
• W2606719182 cites W2776017876 @default.
• W2606719182 cites W32006757 @default.
• W2606719182 cites W789208081 @default.
• W2606719182 doi "https://doi.org/10.2196/resprot.6198" @default.
• W2606719182 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5418526" @default.
• W2606719182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28428158" @default.
• W2606719182 hasPublicationYear "2017" @default.
• W2606719182 type Work @default.
• W2606719182 sameAs 2606719182 @default.
• W2606719182 citedByCount "77" @default.
• W2606719182 countsByYear W26067191822017 @default.
• W2606719182 countsByYear W26067191822018 @default.
• W2606719182 countsByYear W26067191822019 @default.
• W2606719182 countsByYear W26067191822020 @default.
• W2606719182 countsByYear W26067191822021 @default.
• W2606719182 countsByYear W26067191822022 @default.
• W2606719182 countsByYear W26067191822023 @default.
• W2606719182 crossrefType "journal-article" @default.
• W2606719182 hasAuthorship W2606719182A5017597094 @default.
• W2606719182 hasAuthorship W2606719182A5022102010 @default.
• W2606719182 hasAuthorship W2606719182A5030548583 @default.
• W2606719182 hasAuthorship W2606719182A5049930331 @default.
• W2606719182 hasAuthorship W2606719182A5055898059 @default.
• W2606719182 hasAuthorship W2606719182A5066004376 @default.
• W2606719182 hasAuthorship W2606719182A5085558902 @default.
• W2606719182 hasAuthorship W2606719182A5091913728 @default.
• W2606719182 hasBestOaLocation W26067191821 @default.
• W2606719182 hasConcept C107457646 @default.
• W2606719182 hasConcept C126322002 @default.
• W2606719182 hasConcept C142724271 @default.
• W2606719182 hasConcept C159110408 @default.
• W2606719182 hasConcept C168563851 @default.
• W2606719182 hasConcept C170130773 @default.
• W2606719182 hasConcept C1862650 @default.
• W2606719182 hasConcept C204787440 @default.
• W2606719182 hasConcept C27415008 @default.
• W2606719182 hasConcept C2777929519 @default.
• W2606719182 hasConcept C2779363104 @default.
• W2606719182 hasConcept C2780385302 @default.
• W2606719182 hasConcept C2780665704 @default.
• W2606719182 hasConcept C41008148 @default.
• W2606719182 hasConcept C512399662 @default.
• W2606719182 hasConcept C71924100 @default.
• W2606719182 hasConceptScore W2606719182C107457646 @default.

• next